Hostname: page-component-74656f9884-npj9w Total loading time: 0 Render date: 2026-11-08T10:56:39.832Z Has data issue: false hasContentIssue false

Takotsubo cardiomyopathy: how much do we know of this syndrome in children and young adults?

Published online by Cambridge University Press:  13 February 2014

Lazaro E. Hernandez*
Affiliation:
Department of Pediatrics, University of Minnesota, Amplatz Children Hospital, Minnesota, United States of America
*
Correspondence to: Dr L. E. Hernandez, MD, Department of Pediatrics, University of Minnesota Amplatz Children’s Hospital, Minnesota, United States of America. Tel: +612 626 2755; Fax: +612 626 2467; E-mail: herna426@umn.edu
Rights & Permissions [Opens in a new window]

Abstract

Since Takotsubo cardiomyopathy was first described by Sato in 1990, multiple cases have been reported, but only few in children, among whom this type of cardiomyopathy is to some extent underappreciated. A series of children with this syndrome were therefore reviewed, drawing comparison with cases reported by others. The review addresses the current challenges in diagnosis, presentation, triggers, clinical course, management, and possible pathogenic mechanisms of the entity.

Information

Type
Review Articles
Copyright
© Cambridge University Press 2014 
Figure 0

Table 1 Reported cases of takotsubo cardiomyopathy in patients under the age of 20.

Figure 1

Table 2 Series of patients with takotsubo cardiomyopathy.

Figure 2

Figure 1 Twelve-lead electrocardiogram with typical findings in takotsubo cardiomyopathy. ST-segment elevation (black arrows) with T-wave inversion (blue arrows). These findings do not follow a single coronary territory as seen in this ECG, where they are mainly diffused. ST-segment depression and long QTc can be also found in this type of cardiomyopathy.

Figure 3

Figure 2 Two-dimensional echocardiogram with strain analysis of a patient (P1) with takotsubo cardiomyopathy. At presentation (A1, A2), echocardiogram shows a constriction point (white arrows) at the mid-septum and mid-lateral wall of the left ventricle reflecting hyperkinesia of the left ventricular base and hypokinesia of the left ventricular apex adopting a balloon shape (yellow arrows). The 2D strain analysis (A2) reveals a blue area at the left ventricular apex consistent with apical hypokenesia. After 4 weeks, left ventricular function normalised (B1, B2). LA=left atrium; LV=left ventricle; RA=right atrium; RV=right ventricle.

Figure 4

Figure 3 Left ventricle angiography during diastole (a) and systole (b) showing apical and mid-ventricular wall motion abnormalities and hyperkinesia of the basal segment (arrow). Magnetic resonance imaging showing that the akinetic regions are hypoenhanced and dark, suggesting the presence of viable myocardium (c) in contrast with myocardial infarction showing hyperenhancement indicative of necrosis (d).29

Figure 5

Table 3 Proposed Mayo criteria for the clinical diagnosis of takotsubo cardiomyopathy*.

Figure 6

Figure 4 PET/CT and SPECT/CT cardiac fusion imaging in a patient with takotsubo cardiomyopathy. Echocardiography showing remarkable apical ballooning (a). I-beta-methyl iodophenyl pentadecanoic acid images revealed a severely reduced uptake in the apex and a slightly reduce uptake of MIBI in the same region (b)(c). These exams revealed severely impaired fatty acid metabolism rather than myocardial perfusion during the acute phase. The F-fluorodeoxyglucose (FDG) PET image (d) showed an obvious focal FDG accumulation in the apex. F-FDG in the normal myocardium was inhibited. Miyachi H, Kumita SI, Tanaka K. PET/CT and SPECT/CT cardiac fusion imaging in a patient with takotsubo cardiomyopathy. Eur Heart J 2013;34:397. By permission of Oxford University Press. BMIPP=123I-β-methyliodophenyl pentadecanoic acid; MIBI=99mTc-sestamibi.

Figure 7

Figure 5 Proposed mechanisms in the pathogenesis of takotsubo cardiomyopathy. Excess of catecholamines after a stressful event and subsequent effect over the β-receptors is one of the most accepted mechanism. Epinephrine has been implied with the abnormal microvasculature and thus explains the classic electrocardiographic changes. Upregulation of C-fos/C-jun is also involved with abnormalities of the vasculature, especially in post-menopausal women with low estrogen levels. LV=left ventricle.

Figure 8

Figure 6 Periodic acid–Schiff staining (arrows) shows remarkable intracellular accumulation of glycogen in takotsubo cardiomyopathy (a). After functional recovery, only small amounts of glycogen, particularly around the nuclei of the myocites (arrows), were documented. Nef HM, Mollmann H, Kostin S, et al. Tako-tsubo cardiomyopathy: intraindividual structural analysis in the acute phase and after functional recovery. Eur Heart J 2007;28:2456–2464, by permission of Oxford University Press.

Figure 9

Figure 7 Immunohistochemistry of intracellular proteins (specific labelling green, phalloidin red, nuclei blue). α-actin was detected only in the border zone during takotsubo cardiomyopathy (a). After functional recovery, a regular distribution was found (b). N-terminal dystrophin showed a decrease in takotsubo cardiomyopathy, verifying a loss of protein-to-protein interaction (c) in comparison with biopsies after functional recovery (d). C-terminal dystrophin was unaltered in takotsubo cardiomyopathy, suggesting that integrity of the sarcolemma is maintained (e, f). Connexin-43-showed a reduced cell–cell connection in takotsubo cardiomyopathy (g), whereas a myocardial integrity was documented after functional recovery (h). Nef HM, Mollmann H, Kostin S, et al. Tako-tsubo cardiomyopathy: intraindividual structural analysis in the acute phase and after functional recovery. Eur Heart J 2007;28:2456-2464, by permission of Oxford University Press.

Figure 10

Figure 8 Two-dimensional echocardiography showing a left ventricular (LV) thrombus (*) in one of the patients from the series (P5), noticed within 24 hours of the beginning of the symptoms. Contrast echocardiography reveals a non-filling space consistent with the thrombus in the left ventricular apex (b). Complete resolution of the thrombus occurred after 4 weeks of anticoagulation (c). IVS=interventricular septum; RV=right ventricle.